Alzheimer’s clinical research and training awards

42 U.S.C. § 285e–10a
in effect
Sign in to generate a plain English summaryAsk Belisarius Agent
(a) In generalThe Director of the Institute is authorized to establish and maintain a program to enhance and promote the translation of new scientific knowledge into clinical practice related to the diagnosis, care and treatment of individuals with Alzheimer’s disease. (b) Support of promising cliniciansIn order to foster the application of the most current developments in the etiology, pathogenesis, diagnosis, prevention and treatment of Alzheimer’s disease, amounts made available under this section shall be directed to the support of promising clinicians through awards for research, study, and practice at centers of excellence in Alzheimer’s disease research and treatment. (c) Excellence in certain fieldsResearch shall be carried out under awards made under subsection (b) in environments of demonstrated excellence in neuroscience, neurobiology, geriatric medicine, and psychiatry and shall foster innovation and integration of such disciplines or other environments determined suitable by the Director of the Institute.

Starting a business? Corpus forms LLCs in all 50 states and DC.